Tensive Srl's Regenera, a bio-absorbable breast implant, promises to help the millions of women who undergo breast cancer surgery every year, to feel whole again. “While surgery will save many lives, ...

Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium ...

Health Canada posted a report on reduction of red tape, which includes a proposal for mutual recognition of other regulators’ inspections of device and drug manufacturing facilities.

Drug developer stocks rebounded over July and August, with 23 companies on the BioWorld Drug Developers Index posting gains ...

As Avidity Biosciences Inc. brought the second-largest follow-on offering of the year to the market, the company also ...

Autosomal dominant polycystic kidney disease (PKD) is a chronic and debilitating condition affecting over 12 million patients ...

Goodpath Inc., a virtual provider of whole-person care for chronic conditions, raised $18 million in series A financing, led ...

Fibrobiologics Inc. has announced IND-enabling updates from its psoriasis research program demonstrating the potential of ...

Dewpoint Therapeutics Inc. has closed its series D financing to advance DPTX-3186, a first-in-class condensate modulator ...

The American Medical Association has posted the latest update to the current procedural terminology code set, which deletes more than 80 existing codes and adds nearly 290 new codes. Among the new ...

Researchers from Sungkyunkwan University and the Ulsan National Institute of Science and Technology (UNIST) have patented compounds reported to be useful for the treatment of Staphylococcus aureus ...

Biopharma dealmaking remained robust through August 2025, with total disclosed deal value reaching $185.28 billion for the first eight months of the year, the highest January-to-August total in ...